Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$11K Sell
197
-147
-43% -$9.48K ﹤0.01% 486
2022
Q1
$24K Sell
344
-60
-15% -$4.27K ﹤0.01% 433
2021
Q4
$32K Sell
404
-1,201
-75% -$100K ﹤0.01% 404
2021
Q3
$127K Buy
1,605
+29
+2% +$2.33K 0.01% 371
2021
Q2
$124K Hold
1,576
0.01% 393
2021
Q1
$119K Hold
1,576
0.01% 376
2020
Q4
$104K Hold
1,576
0.01% 380
2020
Q3
$85.1K Hold
1,576
0.01% 375
2020
Q2
$75.7K Hold
1,576
0.01% 366
2020
Q1
$53.7K Sell
1,576
-11
-0.7% -$605 0.01% 375
2019
Q4
$99.4K Hold
1,587
0.01% 344
2019
Q3
$79.4K Hold
1,587
0.01% 369
2019
Q2
$76.6K Hold
1,587
0.01% 387
2019
Q1
$81.1K Hold
1,587
0.01% 366
2018
Q4
$57.1K Hold
1,587
0.01% 411
2018
Q3
$98.5K Hold
1,587
0.01% 349
2018
Q2
$83.7K Hold
1,587
0.01% 377
2018
Q1
$87.2K Sell
1,587
-62
-4% -$3.82K 0.01% 368
2017
Q4
$112K Sell
1,649
-115
-7% -$7.74K 0.01% 334
2017
Q3
$126K Buy
+1,764
New +$123K 0.02% 316

Other funds holding ENOV

RBC Europe's ENOV Position: Q2 2022 in Review

RBC Europe reduced its Enovis (ENOV) stake by 43% in Q2 2022, selling an estimated $9.48K and leaving 197 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

RBC Europe first reported a position in ENOV in Q3 2017 and has held it in 20 quarters since. The position peaked at $127K in Q3 2021. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.

  • RBC Europe held 197 shares of Enovis worth $11K as of Q2 2022.
  • RBC Europe sold 147 Enovis shares in Q2 2022, an estimated $9.48K.
  • Enovis made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #486 holding.
  • RBC Europe first reported a position in Enovis in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Enovis position peaked at $127K in Q3 2021.
  • 245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.